Literature DB >> 24931844

Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature.

Brian Chang1, Ashok Tholpady1, Richard S P Huang1, Elena Nedelcu1, Yu Bai1.   

Abstract

Mesh：

Year:  2014        PMID： 24931844      PMCID： PMC4039711          DOI： 10.2450/2014.0222-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  33 in total

1.  Immunoadsorption for the treatment of bullous pemphigoid.

Authors:  N Ino; N Kamata; C Matsuura; H Shinkai; M Odaka
Journal:  Ther Apher       Date:  1997-11

2.  Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid.

Authors:  H Yamada; H Yaguchi; K Takamori; H Ogawa
Journal:  Ther Apher       Date:  1997-05

3.  A major role for neutrophils in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; X Zhou; S J Swartz; J L Troy; J A Fairley; G O Till; L A Diaz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Refractory bullous pemphigoid leading to respiratory arrest and successfully treated with plasmapheresis.

Authors:  J W Konstadt; K Remlinger; J Schild; I Aronson; B Bennin; L Solomon
Journal:  Arch Dermatol       Date:  1990-09

5.  Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.

Authors:  J C Guillaume; L Vaillant; P Bernard; C Picard; C Prost; B Labeille; B Guillot; C Foldès-Pauwels; F Prigent; P Joly
Journal:  Arch Dermatol       Date:  1993-01

6.  Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid.

Authors:  Yukiko Tsuji-Abe; Masashi Akiyama; Yasuko Yamanaka; Toshiro Kikuchi; Kazuko C Sato-Matsumura; Hiroshi Shimizu
Journal:  J Dermatol Sci       Date:  2004-12-02       Impact factor: 4.563

7.  Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

Authors:  E Schmidt; K Obe; E B Bröcker; D Zillikens
Journal:  Arch Dermatol       Date:  2000-02

8.  Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.

Authors:  Yohei Iwata; Kazuhiro Komura; Masanari Kodera; Toshikazu Usuda; Yoko Yokoyama; Toshihide Hara; Eiji Muroi; Fumihide Ogawa; Motoi Takenaka; Shinichi Sato
Journal:  Arch Dermatol       Date:  2008-01

9.  Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.

Authors:  Sho Hiroyasu; Toshiyuki Ozawa; Hiromi Kobayashi; Masamitsu Ishii; Yumi Aoyama; Yasuo Kitajima; Takashi Hashimoto; Jonathan C R Jones; Daisuke Tsuruta
Journal:  Am J Pathol       Date:  2013-01-19       Impact factor: 4.307

10.  BP230- and BP180-specific auto-antibodies in bullous pemphigoid.

Authors:  Sybille Thoma-Uszynski; Wolfgang Uter; Susanne Schwietzke; Silke C Hofmann; Thomas Hunziker; Philippe Bernard; Regina Treudler; Christos C Zouboulis; Gerold Schuler; Luca Borradori; Michael Hertl
Journal:  J Invest Dermatol       Date:  2004-06       Impact factor: 8.551
View more
  2 in total

Review 1.  Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature.

Authors:  Rikke Bech; Line Kibsgaard; Christian Vestergaard
Journal:  Front Med (Lausanne)       Date:  2018-09-04

2.  Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2.

Authors:  Yu Cui; Caixia Hu; Yi Cheng; Xiaomei Han; Wenqing Wang
Journal:  Int J Dermatol       Date:  2021-09-14       Impact factor: 3.204
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.